FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer

A single-nucleotide polymorphism (SNP) in the FGFR4 gene is associated with poor prognosis in solid tumors. A recent study presented the first evidence that FGFR4 Arg388 could predict resistance to adjuvant chemotherapy in breast cancer. The present study evaluates the potential of this SNP to predi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Marmé, Frederik (VerfasserIn) , Werft, Wiebke (VerfasserIn) , Benner, Axel (VerfasserIn) , Burwinkel, Barbara (VerfasserIn) , Sinn, Peter (VerfasserIn) , Sohn, Christof (VerfasserIn) , Lichter, Peter (VerfasserIn) , Hahn, Meinhard (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 10 February 2010
In: Annals of oncology
Year: 2010, Jahrgang: 21, Heft: 8, Pages: 1636-1642
ISSN:1569-8041
DOI:10.1093/annonc/mdq017
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1093/annonc/mdq017
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0923753419394128
Volltext
Verfasserangaben:F. Marmé, W. Werft, A. Benner, B. Burwinkel, P. Sinn, C. Sohn, P. Lichter, M. Hahn & A. Schneeweiss

MARC

LEADER 00000caa a2200000 c 4500
001 1844623440
003 DE-627
005 20230710140307.0
007 cr uuu---uuuuu
008 230504s2010 xx |||||o 00| ||eng c
024 7 |a 10.1093/annonc/mdq017  |2 doi 
035 |a (DE-627)1844623440 
035 |a (DE-599)KXP1844623440 
035 |a (OCoLC)1389806000 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Marmé, Frederik  |d 1974-  |e VerfasserIn  |0 (DE-588)132561972  |0 (DE-627)52394893X  |0 (DE-576)299226549  |4 aut 
245 1 0 |a FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer  |c F. Marmé, W. Werft, A. Benner, B. Burwinkel, P. Sinn, C. Sohn, P. Lichter, M. Hahn & A. Schneeweiss 
264 1 |c 10 February 2010 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.05.2023 
520 |a A single-nucleotide polymorphism (SNP) in the FGFR4 gene is associated with poor prognosis in solid tumors. A recent study presented the first evidence that FGFR4 Arg388 could predict resistance to adjuvant chemotherapy in breast cancer. The present study evaluates the potential of this SNP to predict response to neoadjuvant chemotherapy (NCT) for primary breast cancer (PBC). 
650 4 |a breast cancer 
650 4 |a FGFR4 
650 4 |a neoadjuvant therapy 
650 4 |a pathological complete response 
650 4 |a predictive factor 
650 4 |a single-nucleotide polymorphism 
700 1 |a Werft, Wiebke  |d 1978-  |e VerfasserIn  |0 (DE-588)1012483967  |0 (DE-627)661826945  |0 (DE-576)345464486  |4 aut 
700 1 |a Benner, Axel  |d 1959-  |e VerfasserIn  |0 (DE-588)106584686X  |0 (DE-627)81687221X  |0 (DE-576)425536602  |4 aut 
700 1 |a Burwinkel, Barbara  |d 1969-  |e VerfasserIn  |0 (DE-588)120685760  |0 (DE-627)704924005  |0 (DE-576)292337752  |4 aut 
700 1 |a Sinn, Peter  |d 1957-  |e VerfasserIn  |0 (DE-588)1022590944  |0 (DE-627)717004783  |0 (DE-576)365646342  |4 aut 
700 1 |a Sohn, Christof  |d 1961-  |e VerfasserIn  |0 (DE-588)131349287  |0 (DE-627)507642902  |0 (DE-576)298422255  |4 aut 
700 1 |a Lichter, Peter  |d 1957-  |e VerfasserIn  |0 (DE-588)1096366282  |0 (DE-627)856749915  |0 (DE-576)468019049  |4 aut 
700 1 |a Hahn, Meinhard  |e VerfasserIn  |0 (DE-588)1237450780  |0 (DE-627)176415472X  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
773 0 8 |i Enthalten in  |t Annals of oncology  |d Amsterdam [u.a.] : Elsevier, 1990  |g 21(2010), 8, Seite 1636-1642  |h Online-Ressource  |w (DE-627)320428796  |w (DE-600)2003498-2  |w (DE-576)098134345  |x 1569-8041  |7 nnas  |a FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer 
773 1 8 |g volume:21  |g year:2010  |g number:8  |g pages:1636-1642  |g extent:7  |a FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer 
856 4 0 |u https://doi.org/10.1093/annonc/mdq017  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0923753419394128  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230504 
993 |a Article 
994 |a 2010 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |d 50000  |e 910000PS109972554  |e 910400PS109972554  |e 50000PS109972554  |k 0/910000/  |k 1/910000/910400/  |k 0/50000/  |p 9 
998 |g 1237450780  |a Hahn, Meinhard  |m 1237450780:Hahn, Meinhard  |d 140000  |e 140000PH1237450780  |k 0/140000/  |p 8 
998 |g 1096366282  |a Lichter, Peter  |m 1096366282:Lichter, Peter  |d 50000  |e 50000PL1096366282  |k 0/50000/  |p 7  |y j 
998 |g 131349287  |a Sohn, Christof  |m 131349287:Sohn, Christof  |d 910000  |d 910400  |e 910000PS131349287  |e 910400PS131349287  |k 0/910000/  |k 1/910000/910400/  |p 6 
998 |g 1022590944  |a Sinn, Peter  |m 1022590944:Sinn, Peter  |d 910000  |e 910000PS1022590944  |k 0/910000/  |p 5 
998 |g 120685760  |a Burwinkel, Barbara  |m 120685760:Burwinkel, Barbara  |d 910000  |d 910400  |e 910000PB120685760  |e 910400PB120685760  |k 0/910000/  |k 1/910000/910400/  |p 4 
998 |g 106584686X  |a Benner, Axel  |m 106584686X:Benner, Axel  |d 50000  |e 50000PB106584686X  |k 0/50000/  |p 3 
998 |g 1012483967  |a Werft, Wiebke  |m 1012483967:Werft, Wiebke  |d 50000  |e 50000PW1012483967  |k 0/50000/  |p 2 
998 |g 132561972  |a Marmé, Frederik  |m 132561972:Marmé, Frederik  |d 910000  |d 910400  |e 910000PM132561972  |e 910400PM132561972  |k 0/910000/  |k 1/910000/910400/  |p 1  |x j 
999 |a KXP-PPN1844623440  |e 4318036634 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Marmé","display":"Marmé, Frederik","given":"Frederik","role":"aut"},{"family":"Werft","display":"Werft, Wiebke","given":"Wiebke","role":"aut"},{"display":"Benner, Axel","family":"Benner","given":"Axel","role":"aut"},{"family":"Burwinkel","display":"Burwinkel, Barbara","given":"Barbara","role":"aut"},{"given":"Peter","role":"aut","family":"Sinn","display":"Sinn, Peter"},{"given":"Christof","role":"aut","family":"Sohn","display":"Sohn, Christof"},{"display":"Lichter, Peter","family":"Lichter","given":"Peter","role":"aut"},{"given":"Meinhard","role":"aut","family":"Hahn","display":"Hahn, Meinhard"},{"family":"Schneeweiss","display":"Schneeweiss, Andreas","role":"aut","given":"Andreas"}],"language":["eng"],"title":[{"title_sort":"FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer","title":"FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer"}],"note":["Gesehen am 04.05.2023"],"origin":[{"dateIssuedDisp":"10 February 2010","dateIssuedKey":"2010"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"id":{"zdb":["2003498-2"],"issn":["1569-8041"],"eki":["320428796"]},"recId":"320428796","physDesc":[{"extent":"Online-Ressource"}],"disp":"FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancerAnnals of oncology","type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title_sort":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology","title":"Annals of oncology"}],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"pubHistory":["1.1990 -"],"origin":[{"publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedKey":"1990","dateIssuedDisp":"1990-","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford"}],"part":{"pages":"1636-1642","year":"2010","text":"21(2010), 8, Seite 1636-1642","issue":"8","volume":"21","extent":"7"},"language":["eng"],"corporate":[{"role":"isb","display":"European Society for Medical Oncology"}]}],"recId":"1844623440","physDesc":[{"extent":"7 S."}],"name":{"displayForm":["F. Marmé, W. Werft, A. Benner, B. Burwinkel, P. Sinn, C. Sohn, P. Lichter, M. Hahn & A. Schneeweiss"]},"id":{"eki":["1844623440"],"doi":["10.1093/annonc/mdq017"]}} 
SRT |a MARMEFREDEFGFR4ARG381020